Skeletal muscle abnormalities in rats with experimentally induced heart hypertrophy and failure

被引:13
|
作者
Bernocchi, P
Cargnoni, A
Vescovo, G
Dalla Libera, L
Parrinello, G
Boraso, A
Ceconi, C
Ferrari, R
机构
[1] Fdn Salvatore Maugeri, Cardiovasc Res Ctr, IRCCS, I-25064 Gussago, Brescia, Italy
[2] Hosp Adria, Dept Internal Med, Rovigo, Italy
[3] Univ Padua, CNR, Unit Muscle Physiopathol, I-35100 Padua, Italy
[4] Univ Brescia, Dept Stat, I-25121 Brescia, Italy
[5] Univ Brescia, Chair Cardiol, I-25121 Brescia, Italy
[6] Hosp Brescia, Chair Cardiol, Brescia, Italy
[7] Univ Ferrara, Chair Cardiol, I-44100 Ferrara, Italy
关键词
heart failure; oxidative capacity; skinned muscle fibres; O-2; consumption;
D O I
10.1007/s003950300001
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background In congestive heart failure (CHF), function and metabolism of skeletal muscles are abnormal. Aim To evaluate whether the reduced oxidative capacity of skeletal muscles in CHF is due to impaired 0, utilisation. Methods CHF was induced in rats by injecting 50 mg/Kg monocrotaline. Several animals received the same dose of monocrotaline but only compensated right ventricular hypertrophy and no sign of congestion resulted. Two age- and diet-matched groups of control animals were also studied. in soleus and extensor digitorum longus (EDL) muscles, we studied skeletal muscle blood flow, oxidative capacity and respiratory function of skinned muscle fibres. Results In CHF, we observed a decrease of muscle blood flow (statistically significant in the soleus, p < 0.05 vs. controls). In compensated rats, a similar trend in blood flow was observed. in both soleus and EDL, a significant reduction of high energy phosphate and a shift of the redox potential towards accumulation of reducing equivalents were observed. The reduction of energy charge was not correlated to the decrease of blood flow. In skinned myofibres, the ratio of 0, utilised in the presence and in absence of ADP (an index of phoshorilating efficiency) was reduced from 8.9 +/- 1.9 to 2.7 +/- 0.2 (p < 0.001) and from 5.7 +/- 1.0 to 2.0 +/- 0.3 (p < 0.01) in soleus and EDL, respectively. Activity of the different complexes of respiratory chain was investigated by means of specific inhibitors, showing major abnormalities at the level of complex I. In fact, inhibition of VO2 by rotenone was decreased from 83.5 +/- 3.2 to 36.4 +/- 9.6 % (p < 0.005) and from 81.8 +/- 6.1 to 38.2 +/- 7.4 % (p < 0.005) in soleus and EDL, respectively. Conclusions In rats with CHF, abnormalities of oxidative phosphorylation of muscles occur and complex I of the respiratory chain seem to be primarily affected. The metabolic alterations of skeletal muscles in CHF may be explained, at least in part, by an impaired O-2 utilisation.
引用
收藏
页码:114 / 123
页数:10
相关论文
共 50 条
  • [31] TNFa and sphingosine are the cause of apoptosis in the skeletal muscle of rats with heart failure
    dalla Libera, L
    Sabbadini, R
    Renken, C
    Ravara, B
    Sandri, M
    Betto, R
    Angelini, A
    Vescovo, G
    EUROPEAN HEART JOURNAL, 2001, 22 : 397 - 397
  • [32] Impaired capillary hemodynamics in skeletal muscle of rats in chronic heart failure
    Kindig, CA
    Musch, TI
    Basaraba, RJ
    Poole, DC
    JOURNAL OF APPLIED PHYSIOLOGY, 1999, 87 (02) : 652 - 660
  • [33] ULTRASOUND MODULATES SKELETAL MUSCLE CYTOKINE LEVELS IN RATS WITH HEART FAILURE
    Rossato, Douglas Dalcin
    Dal Lago, Pedro
    Hentschke, Vitor Scotta
    Rucatti, Ananda Lazzarotto
    Signori, Luis Ulisses
    Silveira, Matheus Noronha
    Plentz, Rodrigo Della Mea
    ULTRASOUND IN MEDICINE AND BIOLOGY, 2015, 41 (03): : 797 - 805
  • [34] Effects of gowth hormone administration on skeletal muscle of rats with aortic stenosis-induced heart failure
    Lima, A. R. R.
    Damatto, R. L.
    Campos, D. H. S.
    Martinez, P. F.
    Bonomo, C.
    Guizoni, D. M.
    Cezar, M. D. M.
    Zanati, S. G.
    Okoshi, K.
    Okoshi, M. P.
    EUROPEAN HEART JOURNAL, 2012, 33 : 490 - 490
  • [35] GH differentially modulates skeletal muscle proteins in rats with aortic stenosis-induced heart failure
    Lima, A. R. R.
    Damatto, R. L.
    Pagan, L. U.
    Gomes, M. J.
    Bonomo, C.
    Cezar, M. D. M.
    Damatto, F. C.
    Gaiolla, P. S. A.
    Okoshi, K.
    Okoshi, M. P.
    EUROPEAN HEART JOURNAL, 2015, 36 : 671 - 672
  • [36] SKELETAL-MUSCLE METABOLISM IN HEART-FAILURE - ABNORMALITIES DURING ISCHEMIC EXERCISE
    MASSIE, BM
    CONWAY, M
    RAJAGOPALAN, B
    YONGE, R
    FROSTICK, S
    SLEIGHT, P
    LEDINGHAM, J
    RADDA, G
    CLINICAL RESEARCH, 1987, 35 (03): : A303 - A303
  • [37] BIOENERGETIC ABNORMALITIES OF SKELETAL-MUSCLE IN HEART-FAILURE ARE NOT REVERSED BY CARDIAC TRANSPLANTATION
    STRATTON, JR
    KEMP, GJ
    DALY, R
    YACOUB, M
    RADDA, G
    RAJAGOPALAN, B
    CIRCULATION, 1992, 86 (04) : 693 - 693
  • [38] Abnormalities of skeletal muscle metabolism in patients with chronic heart failure: Evidence that they are present at rest
    Andrews, R
    Walsh, JT
    Evans, A
    Curtis, S
    Cowley, AJ
    HEART, 1997, 77 (02) : 159 - 163
  • [39] CONTRACTILE STATE OF CARDIAC MUSCLE OBTAINED FROM CATS WITH EXPERIMENTALLY PRODUCED VENTRICULAR HYPERTROPHY AND HEART FAILURE
    SPANN, JF
    BUCCINO, RA
    SONNENBLICK, EH
    BRAUNWALD, E
    CIRCULATION RESEARCH, 1967, 21 (03) : 341 - +
  • [40] MUSCLE HYPERTROPHY EXPERIMENTALLY-INDUCED BY ADMINISTRATION OF DENERVATED MUSCLE EXTRACT
    JIMENA, I
    PENA, J
    LUQUE, E
    VAAMONDE, R
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 1993, 52 (04): : 379 - 386